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ABSTRACT: Partially covered self-expandable metallic esophageal stent (SEMS) placement is the most frequently applied
palliative treatment in esophageal cancer. Structural characterization of explanted 16 nitinol-polyurethane SEMS (the group of 6
females, 10 males, age 40−80) was performed after their removal due to dysfunction. The adverse bulk changes in the polymer
structure were identified using differential scanning calorimetry (DSC), differential mechanical thermal analysis (DMTA), and
attenuated total reflectance infrared spectroscopy (ATR-IR) and discussed in terms of melting point shift (9 °C), glass-transition
shift (4 °C), differences in viscoelastic behavior, and systematic decrease of peaks intensities corresponding to C−H, CO, and C−
N polyurethane structural bonds. The scanning electron and confocal microscopic observations revealed all major types of surface
degradation, i.e., surface cracks, peeling off of the polymer material, and surface etching. The changes in the hydrophobic
polyurethane surfaces were also revealed by a significant decrease in wettability (74°) and the corresponding increase of the surface
free energy (31 mJ/m2). To understand the in vivo degradation, the in vitro tests in simulated salivary and gastric fluids were
performed, which mimic the environments of proximal and distal ends, respectively. It was concluded that the differences in the
degradation of the proximal and distal ends of prostheses strongly depend on the physiological environment, in particular stomach
content. Finally, the necessity of the in vivo tests for SEMS degradation is pointed out.
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■ INTRODUCTION
Every sixth death in the world is due to cancer, the second
leading cause of death.1 Esophageal cancer is one of the most
commonly diagnosed cancers and the sixth leading cause of
cancer-related mortality.2 Due to either a progressive tumor
stage or weak physical conditions, the majority of patients are
not eligible for curative treatment.3 The most important aspect
of esophageal cancer is dysphagia, which is a late symptom of
esophageal cancer, leading to weight loss, eating disorders, and
related metabolic deficiencies; thus, to improve the quality of
patients’ life, a palliative treatment must be applied.4
Stent treatment is well documented and commonly applied
on a large scale for palliative treatment of dysphagia and fistula
caused by advanced esophageal cancer. Clinical research
confirmed that esophageal stent implantation has satisfying
results, leading effectively to patients’ relief.5 The esophageal
stenting is a relatively easy method, used for the first time in
1885. Since then, rapid development due to the advances in
endoscopy has been observed.6
Nowadays, esophageal stents consist of two main
components of different functions: nitinol mesh (superelastic
shape memory alloy for expansion) and polymeric membrane
(biocompatible cover), schematically presented in Figure SI.1.
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Such composite construction combines the advantages of the
mechanical performance of metal alloy and elastic polymeric
barrier, preventing tumor overgrowth.7 Self-expandable metal
stents (SEMSs) are available in three variants, uncovered,
partially covered, and fully covered with flanges at both ends,
resulting in a “dog bone” shape.8 The greatest benefit of using
SEMSs is their sufficient elasticity to be compressed for
delivery and expanded after implantation in the target area
within 24 h at the patient’s body temperature.9
Although the stent implantation procedure is rather simple
and limits surgical invasion during stenting, there is still a risk
of life-threatening complications. The most frequent post-
operation complications are prosthesis migration, esophageal
perforation, and overgrowth of the stent by the granulation
tissue (hyperplastic tissue reaction). Moreover, there is a
possibility of more serious consequences such as hemorrhage
and fistulas between the esophagus and the bronchial tree or
mediastinum.4,10−12 The factors causing the complications are
poorly understood; however, despite the side effects, stenting
still ensures improvement in the quality of life of palliative
patients.
As suggested by producers, the maximum residence time of
the prosthesis is 3 months. However, due to the above-
mentioned complications, it is unachievable in many cases. A
new approach in improving the quality of palliative treatment
can be provided by local heat treatment using a nano-
functionalized SEMS13 or functionalization of the SEMS
polymeric barrier with chemotherapeutic agents (docetaxel,
paclitaxel, fluorouracil), antibiotics (doxorubicin), or radio-
therapeutic agents (iodine-125, holmium-166).14−18 It is also
worth mentioning the new generation of stents covered with a
biodegradable polymer, which can be additionally equipped
with a drug-eluting function. Some of their successful
applications include covering a metal stent with a poly-
caprolactone (PCL)-based fibrous membrane containing
paclitaxel.19 Such an approach allows in-site chemotherapy
and effectively reduces the risk of restenosis.20
Polyurethanes (PUs), due to their specific physicochemical
properties,21−23 have a broad gamut of medical applications in
various fields including coating technology (coatings of
orthopedic metal implants, wound dressings24), bulk bio-
materials (middle ear implants),25 and scaffolds (orthopedic
and cardiovascular).26,27 Polyurethanes are also suitable for
applications as cardiovascular,28 neurological,29 and esophageal
stents.30 The polymeric membranes made of polyurethanes are
used for over 25 years as short-term biomedical devices.31,32
The three principal components of PU include polyol,
diisocyanate, and cross-linker between which a urethane
linkage (−NHCOO−) is formed. There is a variety of possible
polyols (over 500 commercially used) that play an important
role in controlling the characteristics of the PUs, such as
physicochemical and mechanical properties.33 The PUs used as
biomaterials are polyether- and polyester-based, and their
choice depends on the application site. Polyether-based PUs
are flexible and resistant to hydrolysis but have low oxidative
and thermal stabilities, while polyester-based PUs have greater
mechanical strength and heat resistance, though susceptible to
hydrolytic degradation.34
To improve the polyurethane performance, intense studies
are carried out, e.g., to enhance hemocompatibility and
antibacterial activity. Two main paths of the PU surface
modification are focused on the implementation of substances
with a specific function (e.g., antibiotics, metallic nanoparticles,
growth factors, natural polymers), or generation of active
groups on polymeric surfaces by plasma treatments, flame
treatment, UV irradiation, and chemical grafting.35,36
The polyurethane membranes of esophageal stents that
prevent tumor overgrowth should be stable and ensure reliable
support against dysphagia, and in long-term use, a significant
loss of biostability is observed.37,38 The degradation is caused
by the very aggressive environment of the body fluids, living
tissues, and a combination of physical and chemical processes
at the implant−body interface such as hydrolysis, oxidation
stress, environmental stress cracking, and calcification.39−41
Crack formation and propagation on the surface of the
polyurethane is mainly caused by environmental stress. In
general, the breaks in the polymer chain caused by the
synergistic effects of chemical degradation and mechanical
stress generate microscopic defects, leading to the formation of
cracks and their propagation on the surface.37 Such
degradation of PU-based implants results in a decrease in
mechanical strength. The process of in vivo degradation
depends on many factors, i.e., it is assumed that both the
environmental factors of patients (cancer stage and aggressive-
Table 1. Basic Information on the Investigated SEMS
treatment
patient gender stenting chemotherapy radiotherapy complication residence time (days)
1 M + + + bronchus fistula 35
2 F + + + granulation 66
3 F + granulation 153
4 M + + + migration 68
5 M + + + granul. empyema 91
6 M + + + none 93
7 F + + + none 98
8 M + + + granulation 82
9 M + + + granulation 45
10 M + + + bronchus fistula 38
11 M + + + none 101
12 F + + + granulation 31
13 M + + + bronchus fistula 81
14 F + + + granulation, dysphagia 65
15 M + + + granulation, dysphagia 48
16 F + + granulation 62
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ness, health/condition) and the treatment (chemotherapy,
radiotherapy) play an important role here. Unfortunately, the
exact causes are unknown, because no scientific attempts have
been made to assess them so far, and there are no systematic
scientific reports, especially for in vivo conditions.
The aim of this study was to compare the reference (as
received from the producer) and implanted stents (removed
from patients after 1−6 months) in terms of surface and bulk
changes in the polyester-based polyurethane membranes. Such
an approach requires application of a broad range of
physicochemical methods dedicated to the thorough character-
ization of polymeric materials such as differential scanning
calorimetry (DSC), differential mechanical thermal analysis
(DMTA), attenuated total reflectance infrared spectroscopy
(ATR-IR), scanning electron microscopy (SEM), confocal
microscopy (CM), and contact angle (CA) measurements.
■ MATERIALS AND METHODS
Patients. Sixteen patients (10 men, 6 women in the age group of
42−82, average age 59) were palliatively treated for esophageal tumor
by the placement of self-expandable polyurethane stents (SEMS,
made of a nitinol mesh and covered with a polymeric membrane with
flanges at the proximal and distal ends.) Two main treatments were
applied, chemotherapy and radiotherapy. SEMSs were removed from
living patients by endoscopy due to total dysphagia caused by an
overgrowth of noncancerous granulation above or below the
implanted prosthesis or during esophageal resection. Esophagus
resection was not a routine surgical procedure for patients qualified to
palliative treatment. A detailed summary of patients’ information
(treatments, re-treatments, and complications) is listed in Table 1.
Samples. The removed esophageal stents were cut into three parts
(proximal, distal, and middle). Each one was stored separately. Prior
to the investigations, for thorough cleaning from adsorbed organic
residues (mainly proteins and bacterial biofilm), the samples were
placed in a beaker with distilled water and kept in an ultrasonic
cleaner for 10 min. After the cleaning, the samples were air-dried.
Material Characterization. Differential Scanning Calorimetry
(DSC). The changes in bulk properties of polyurethane were analyzed
using a DSC 821e Mettler Toledo apparatus. The experiments were
performed in the temperature range of 25−600 °C with a heating rate
of 10 °C/min at an Ar flow.
Dynamic Mechanical Thermal Analysis (DMTA). A Q800 DMA
(TA Instruments, New Castle, DE) apparatus operating in a tensile
mode was used to determine the storage modulus (E′), loss modulus
(E″), and the tangent of the phase angle (tan δ). The glass-transition
temperature (Tg) was taken as the maximum of tan δ and the
maximum of loss modulus, E″. The relaxation spectrum was scanned
from −70 to 150 °C, at a frequency of 1 Hz and a heating rate of 3
°C/min.
Attenuated Total Reflectance Infrared (ATR-IR) Spectroscopy.
ATR-IR spectroscopy was performed to study the bulk changes in the
stents’ polymeric component. The measurements were carried out on
a Nicolet 6700 Thermo Scientific with a diamond crystal. The spectra
were acquired in the range of 4000−600 cm−1, and for each sample,
the result is an average of 64 scans.
Scanning Electron Microscopy (SEM). The images of eroded
samples’ surfaces for the polymer and nitinol were taken using a
Hitachi S-4700 scanning electron microscope. The polyurethane
samples were coated with Au prior to the observations due to their
nonconductive nature.
Confocal Microscopy. The images of polymeric samples to
measure their roughness were taken using an Olympus Lext
OLS4000 confocal microscope (magnification, 10×; image size,
1280 × 1281 μm2). Surface roughness was calculated based on the
formula for Ra, which is the arithmetic average of the absolute values
of the profile height deviations from the mean line, recorded within
the evaluation length. The typical image used for evaluation of surface
roughness is presented in Figure SI.2.
Contact Angle (CA) Measurements and Surface Free Energy
(SFE) Calculations. The changes in the hydrophobicity caused by
human body fluids were followed by contact angle measurements,
using a Surftens universal instrument (OEG GmbH). Static contact
angles of water and diiodomethane were calculated using software
Surftens 4.3. For each sample, at least three 1 μL droplets of water and
diiodomethane were applied, respectively. The mean value was the
average over 10 independent measurements. SFE calculations, based
on contact angle values of water and diiodomethane, were performed
using the standard Owens−Wendt method dedicated to polymeric
surfaces. The method of calculation and equations are described in
detail in our previous work.42
In Vitro Aging Test of Polyurethane Membrane. To get more in-
depth insight into polyurethane membrane degradation, in vitro tests
were performed. For the best imitation of the stent environment in
the human body (for the proximal and distal ends), two types of body
fluids were used: artificial saliva and simulated gastric fluid. A
modified Fusayama’s artificial saliva (AS) was used at 37 °C (pH 6),
with the following chemical composition: NaCl (0.4 g/L), KCl (0.4
g/L), CaCl2·2H2O (0.795 g/L), Na2S·9H2O (0.005 g/L), NaH2PO4·
2H2O (0.69 g/L), and urea (1 g/L).
43 Simulated gastric fluid without
pepsin, 0.2% (w/v) NaCl, in 0.7% (v/v) HCl, pH 1.5, was prepared.44
In vitro experiments were performed for 62 days at 37 °C in an
incubator with gentle shaking (60 rpm). The simulated body fluids
were replaced every 7 days. The samples were collected for 7, 14, 21,
and 62 days.
■ RESULTS AND DISCUSSION
The polyurethane prosthesis membranes were thoroughly
characterized in terms of bulk and surface properties to
determine the effect of cancer therapy on their structure. Bulk
changes in the polyurethane structure were investigated using
DSC. Measurements were performed for prostheses exposed to
various patient treatments: stenting, chemotherapy, chemo-
therapy, and radiotherapy. The DSC curves for representative
samples are shown in Figure 1a for the prosthesis proximal end
Figure 1. DSC profiles and the characteristic Tmelt values for proximal
(a) and distal (b) ends of SEMS polyurethane cover. The inset in (b)
shows a narrow range of Tmelt for the distal end of the prostheses.
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and in Figure 1b for the distal end. The characteristic
parameter that indicates the changes in the polymer bulk
properties is melting temperature (Tmelt); in the case of the
reference sample, Tmelt = 365 °C. For the implanted samples,
significant differences in Tmelt for proximal and distal ends were
observed (for details, see the inset in Figure 1). In general, the
observed trend for the proximal end is increase in Tmelt in the
narrow range of 367−368 °C, while for the distal end, the
values are spread in the larger range of 356−369 °C, as shown
in Figure 2 (the error bars correspond to 0.2 °C). The
temperature shift (∼9 °C) for stent 2 and stent 3 points out
significant bulk changes in the polymeric structure. It is worth
mentioning that these samples are representatives of the
material, which underwent combined chemo- and radiotherapy
(stent 2) and the longest implantation time of 153 days (stent
3). The results also indicate that the distal end of the
prosthesis, exposed to harsher environment conditions (i.e.,
stomach content), is more damaged in contrast to the proximal
end, where the changes in the polymeric structure are minor.
This also clearly illustrates that the chemistry of degradation
processes is different on both prosthesis ends, i.e., the increase
and decrease in Tmelt of proximal and distal ends, respectively.
Since melting temperature is characteristic of the structure of
polymeric material, the degradation processes of the examined
materials are not confined to the surface but advanced into the
bulk. For detailed in-depth characterization of the polymer in
vivo degradation and difference between distal and proximal
sides, dynamic mechanical thermal measurements were
performed. DMTA allowed for a detailed analysis of the
temperature-dependent viscoelastic properties and gave in-
sights into the mechanical behavior of the investigated
polymeric membranes.
The DMTA results are summarized in Figures 3 and 4,
where values of the storage modulus, E′, are presented. The E′
values (Figures 3a and 4a) represent elastic behavior in
viscoelastic polymers and indicate a clear difference in the
elasticity with the change of various patients’ treatment:
stenting, chemotherapy, and combined chemo- and radio-
therapy. These changes can also be seen in E′ for proximal
(Figure 3a) and distal (Figure 4a) ends of the polymeric stents
cover. The highest difference in E′ between reference and
implanted materials in the low-temperature region (before the
sharp decrease around the glass-transition temperature, Tg) has
been noted for explants after stenting and chemotherapy for
the proximal end, while for the distal end, the combination of
stenting, chemotherapy, and radiotherapy had the most
pronounced effect. Interestingly, all explanted stents from the
distal region revealed typical for thermoplastic polyurethanes
rubbery plateau, not observed for the reference material. This
can indicate significant changes in the microphase separation
and crystalline structure changes as these materials (stents 2
and 3, Figure 3a) show very distinct flow properties (melting
transition). Figures 3b,c and 4b,c show storage modulus, E″,
and tan δ curves, respectively. The maximum of E′ and tan δ
value is often referred to Tg in thermoplastic polyurethane
elastomers, and the values of the maxima of these transitions
are summarized in Table 2. Again, the largest differences in Tg
(taken as the maximum of E″) between the reference material
and explanted PU has been found for the distal end after
combined stenting, chemotherapy, and radiotherapy (Figure
4b). A significant broadening of the tan δ curves for explants
after such treatment clearly indicates that changes in materials’
microstructure have occurred, which is in line with the DSC
results.
The more in-depth insight into the chemical changes in the
polyester polyurethane molecular structure can be obtained by
infrared spectroscopy; therefore, the examined prostheses were
investigated using ATR-IR, and the representative spectra are
presented in Figures 5 and 6. The characteristic maxima for
polyurethane are observed at 2930 and 2858 cm−1
(asymmetric CH2 stretch vibration),
45 1738 and 1716 cm−1
(CO stretch vibration),45,46 1524 cm−1 (coupling N−H
blending vibration with C−N stretching vibration),46 1463 and
1403 cm−1 (CH2 bending vibration),
47 1244 cm−1 (amine III
vibration, C−N), 1044 cm−1 (antisymmetric C−O−C),47 955
cm−1 (C−H benzene ring out-of-plane bending),48 and 790
cm−1 (amine IV vibration).49 Although the overall IR spectra
are essentially similar, the detailed analysis of the three regions
Figure 2. Changes of Tmelt with implantation time for proximal (▲)
and distal (■) ends of SEMS polyurethane (colors represent patients’
treatment: blue, chemotherapy; green, chemo- and radiotherapy;
orange, palliative treatment only, i.e., stenting).
Figure 3. Storage modulus, E′ (a), loss modulus, E″ (b), and tan δ (c) profiles for the proximal end of SEMS polyurethane covers.
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assigned to −CH2 (3000−2800 cm−1), CO (1800−1600
cm−1), and C−N (1300−1150 cm−1) shows systematic
changes in the characteristic bond absorption intensities, as
presented in the bottom panels of Figures 3 and 4, respectively.
This indicates that the extensive degradation process of the
polymer took place upon implantation in the case of all of the
investigated samples and the damage of distal ends is much
greater compared to the proximal end. The ATR-IR results are
in line with the Tmelt values obtained using DSC, since again
for the prosthesis numbers 2 and 3, the changes were the most
pronounced in terms of all of the observed chemical groups,
mainly CH2, CO, and C−N.
All of the methods (DSC, DMTA, and ATR-IR)
complementarily revealed advanced changes in material
properties. These adverse bulk changes are the effect of the
surface damages caused by the aggressive environment of the
body fluids and living tissues, which penetrate the material;
therefore, scanning electron and confocal microscopic
observations were performed to illustrate the changes in
surface morphology. The representative images of the
investigated samples are presented in Figures 7−10.
The SEM images illustrate the morphological differences in
polymeric coating between the outer (dedicated to contact the
tissue) and inner sides, as presented in Figure 7a,b. The outer
surface of the polymer is smoother than the inner side, which
has micro- (30−50 μm) and submicropores (>10 μm). On the
top of each side, granulated particles (white spots) are
observed, which were identified by independent X-ray
fluorescence (XRF) measurements as magnesium oxide
particles.
After implantation, the topography of the surface dramat-
ically changed. The typical examples of prostheses morphol-
ogies are shown in Figure 8, where different types of surface
damages can be observed. Placing the implants in the human
body led to several processes resulting in severe changes in the
surfaces of the implant. Indeed, in Figure 8, cracks (Figure
8a,c), peeling (Figure 8a), and material surface transformation
Figure 4. Storage modulus, E′ (a), loss modulus, E″ (b), and tan δ (c) profiles for the distal end of SEMS polyurethane covers.
Table 2. Glass-Transition Temperature (Tg) of Polymeric
Materials Covering Stents as Determined from DMTA as
the Maximum of E″ or the Maximum of tan δaa
sample code Tg (max E″) (°C) Tg (max tan δ) (°C)
stent 2 (66 days; S, R, C) −21.62 (−23.02) −14.81 (−14.85)
stent 3 (153 days; S) − (−21.51) − (−14.25)
stent 8 (82 days; S, R, C) −23.21 (−24.45) −15.23 (15.18)
stent 16 (62 days; S, C) −21.31 (−23.44) −13.90 (−14.40)
reference −19.03 (−19.03) −11.45 (−11.45)
aTg (max E″), glass-transition temperature taken from the maximum
of storage modulus, E″; Tg (max tan δ), glass-transition temperature
taken from the maximum of tan δ. The numbers outside parentheses
refer to the proximal end of the stent; the numbers within parentheses
refer to the distal end of the stent. S, stenting; C, chemotherapy; R,
radiotherapy.
Figure 5. ATR-IR spectra of SEMS polyurethane covers: reference
sample and selected stents (proximal end).
Figure 6. ATR-IR spectra of SEMS polyurethane covers: reference
sample and selected stents (distal end).
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from micron and submicron pores (Figure 8b) to ∼100 μm
craters (Figure 8d) in the polymeric surface can be observed,
indicating that the destruction processes are quite extensive.
This is particularly visible for the inner side of the stents.
During the implantation, the surface of the polymeric
component was coated with various human proteins and
macrophages, which can strongly enhance the surface
degradation process of biomaterials by the extensive release
of oxygen free radicals.50−52 In Figures 9 and 10, more in-
depth morphology analyses for prostheses 16 and 8 are
presented, respectively. For combined chemo- and radio-
therapy (stenting for 62 days), as well as prolonged residence
in the body (82 days), all major types of surface degradation
can be distinguished, i.e., polyurethane surface cracks, peeling
off of the material, and surface etching. Thus, it can be
suggested that the degradation processes taking part at the
polymeric surface are interlaced.
To eliminate the effect of biological moieties we performed
in vitro degradation tests of polyurethane membrane in
simulated salivary and gastric fluids, representing the environ-
ment where the proximal and distal ends are placed. The
corresponding images are presented together with in vivo
results (Figures 9 and 10; see Figures SI.3−SI.6 for images
from more systematic studies). The images clearly illustrate
that the simulated body fluids alone already cause the
degradation of the material. The walls of the pores become
thinner (Figures 9b and 10b), whereas the longer incubation
time results in characteristic cracks. It can also be noted that on
the polymeric surface, the crystalline precipitates are formed,
which contain the typical ions presented in the simulated saliva
(Na+, K+, Ca2+, PO4
3−, Cl−). It is mostly visible in the case of
artificial saliva (pH 6) since the high ionic strength of the
gastric solution (pH 1.5) hinders the formation of the
precipitated salts.
To quantify the surface changes caused by the degradation,
the surface roughness was evaluated using a confocal
microscope. The changes in Ra values (representing surface
roughness) for the samples after in vitro tests are summarized
in Figure 11. As can be inferred from the nonmonotonous
changes of Ra with time, there are several individual processes
involved in the overall degradation mechanism. In the first
stage (first 2 weeks) of degradation, the pores expand, they
become deeper, and their walls become thinner, which is
reflected in a substantial increase in the Ra value. When the
degradation process prolongs, Ra decreases due to the salt
precipitation in the pores and the destruction of the walls. In
line with the SEM observations and spectroscopic data
(Figures 5, 6, 9, and 10), the changes in roughness clearly
Figure 7. Representative images of reference sample morphology of SEMS polyurethane cover: outer side (a) and inner side (b) of the stent.
Figure 8. Representative SEM images of SEMS polyurethane covers
with visible surface damages appearing after 9−12 weeks implantation
time.
Figure 9. Representative SEM images illustrating the surface degradation (prosthesis 16) for the proximal end of the esophageal implant (a) and
for parallel in vitro experiment in artificial saliva for 2 months (b).
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show the differences in the degradation process under two in
vitro conditions (saliva, gastric), mostly manifested after a
longer time. Surface irregularities play an important role in the
tissue−implant interface. The increase in roughness and
related increase in the surface area available for tissue
overgrowth may accelerate restenosis, as observed in clinical
practice (J.W. and J.K., private information).
Additional surface characterization was provided by the
water contact angle measurements; this method quantitatively
characterizes the wettability and allows for surface free energy
(SFE) determination, often used for evaluation of the
biological interactions such as adhesion of proteins, cells, or
tissues. The exposure of the esophageal stent to human body
fluids causes significant changes in the surface properties of the
polymeric membrane. The polyurethane cover of the
esophageal stent is initially hydrophobic, as revealed by the
water contact angle of 123 ± 2° and the corresponding SFE =
24 mJ/m2 for the reference material. The changes induced by
prolonged interaction with body fluids strongly affect the
examined prostheses with a significant decrease in average
water contact angle down to 49 ± 15° (Figure 12). This can be
explained by changes in the surface morphology, especially
degradation and physical damages observed in SEM images
and Ra (Figures 7−11). Nevertheless, it is worth underlying
that although the SEM observations provide local information
about the degradation, the contact angle measurements
characterize the macroscopic changes at the polymeric surface.
As can be observed in Figure 12b, independently the type of
complications (granulation, bronchus fistula), the overall trend
in contact angle changes is the same: the longer the
implantation time, the smaller the contact angle value. The
observed trend indicates that polymer degradation is stable
within the investigated range of implantation time. The gray
shadowing corresponds to the time recommended by the
implant producer and was achieved only for stents without
complications. It can also be noted that in the case of bronchus
fistula, the water contact angle values were lower than those for
granulation.
The various methods of the prostheses’ structure examina-
tion show the different character of the changes in the distal
and proximal segments of the prostheses’ polymer. The
structural changes result from the influence of the applied
chemo- and radiotherapy treatment, mechanical stress, as well
as the influence of the esophagus and gastric contents. Since
the major damage was also observed for the prosthesis not
exposed to chemo- or radiotherapy, the surrounding environ-
ment of the SEMS is a sufficient factor to elicit significant
surface and structural changes in the polyurethane mem-
brane.53,54 The SEM/CM observations confirmed that the
destruction processes are quite extensive and interlaced,
resulting in etching and peeling off of the material. The
observed crack formation and propagation on the surface of
the polyurethane are mainly connected with the high
mechanical stress generated by nitinol mesh as well as the
surrounding tissue pressure. Thus, it can be concluded that the
Figure 10. Representative SEM images illustrating the surface degradation (prosthesis 8) for the distal end of the esophageal implant (a) and for in
vitro experiment in simulated gastric fluid for 2 months (b).
Figure 11. Surface roughness (parameterized by Ra) as a function of
incubation in simulated body fluid (gastric and salivary) together with
graphical representations showing the changes in surface topography.
Figure 12. Representative results of water contact angle measure-
ments and the corresponding surface free energy for the investigated
SEMS polyurethane covers (a): reference (navy blue) and implanted
prostheses (blue). The shadowing illustrates the range of experimental
values for the investigated samples. Detailed analysis of water contact
angle measurements as a function of time in the human body (b).
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applied polyurethane material has insufficient mechanical
strength resistance for prolonged use in the body.
The chemical degradation of polyurethanes is mainly caused
by hydrolysis as thoroughly discussed elsewhere.55,56 This type
of degradation is a combination of in vivo chemical factors such
as water sorption, pH, presence of radicals, and biological
moieties like cells, enzymes, and lipids. Since the water
molecules mostly interact with the polyurethane polar groups,
the hydrolytic degradation is dominating and affects carbonyl
bands (changes in IR spectra at 1730 cm−1 in Figures 5 and 6).
As shown in Figures 9−11, the interaction with simulated body
fluids already leads to surface damages and microscopic
cracking. However, as reported for in vivo conditions,57
biological factors (i.e., FBGC, enzymes) accelerate the
hydrolytic degradation, which can be additionally enhanced
by mechanical stress. It is also known that the cracks initiated
by chemical interaction can be propagated by residual stress.
This in turn causes an increase in the surface area and the
number of available surface sites that accelerate the hydrolytic
degradation even further.58 It is worth mentioning that the
biological degradation is diffusion-limited and thus confined to
a few microns and thus can be considered as a mostly surface
process. It can be thus concluded that although the cracks may
open the diffusion pathways for bulk degradation, the obtained
results (SEM, IR, CM−Ra) indicate that the polyurethane
degradation process begins at the surface. Such results are in
good agreements with the previously reported in vivo
investigations.51
In the studied group, it was found that among patients with
fistula, the polymeric surface was exposed to body fluids for a
shorter time (35−81 days) than in the group with granulation
(31−153 days). The mechanism of polymer degradation can
be one of the factors leading to a life-threatening complication,
which is a fistula to the bronchial tree. The formation of
granulation tissue after the implantation of the esophageal
prosthesis is a typical complication occurring in the range of
4−40%59,60 (in our work, 11%). It is formed in the distal and
proximal ends of the prostheses in healthy tissues of the
esophagus as well. The granule is a noncancerous connective
tissue that surpasses the prosthetic ends most likely due to the
exudation of the mechanical stress of the nitinol mesh on the
esophageal mucosa.61,62 Based on our operating room
observations, such an effect can be caused by a lack of
SEMS nitinol biomechanical compatibility causing irradiation
of the esophageal wall, likely causing granulation. Moreover,
the irradiation at the esophageal wall−prosthesis interface is
enhanced by the progressive degradation of the polymer bulk
and surface. The granulation tissue grows up to about 3
months after the prosthesis implantation, leading to complete
obstruction of the esophageal stent, which in turn leads to
endoscopic removal of the prosthesis, already at high risk of
complications. The mechanism of granulation formation may
be also related to the destructive effect of acid gastric contents,
especially in its distal segment.
The influence of prosthetics, irradiation, and chemotherapy
on the esophagus and the occurrence of complications after
stenting in the course of cancer remain unclear. The observed
changes in the microstructure of the esophagus and secondary
changes in the esophageal wall are important for the
pathophysiology. Factors determining their occurrence are
yet to be investigated, and the presented report clearly shows a
need and direction for further research. The degradation of
polyurethanes is mostly examined in vitro, and in many cases in
stable environments under favorable temperature condi-
tions.63,64 Such experiments performed under controllable
conditions do not provide thorough feedback of the material in
such a complex system as the human body. Within this study,
we address this knowledge gap. The in-depth insights are the
prerequisites for the development of new-generation pros-
theses with better parameters, which can minimize the
traumatic impact of the foreign body on the esophagus.
The performed studies clearly point out the important
practical implications and the need for different optimization
of the polymeric material, specifically for each end of the stent.
The hydrophilic/hydrophobic polymeric surfaces at the outer
and inner sides of the implant will be beneficial to provide
biocompatibility and prevent obstruction, respectively. Such
modification can be obtained using plasma treatment
(introduction of surface functional groups such as −OH or
−F without changing the bulk properties). Another strategy
consists of improving the chemical inertness and mechanical
properties by applying polymeric composites with tunable
properties.
■ CONCLUSIONS
In this work, we have evaluated the effect of the human body
environment and the applied cancer treatment on the
degradation process of the polyurethane SEMS membranes.
The obtained physicochemical characterization of 16 stents
removed from the patients revealed that independent of the
treatment (chemo- and/or radiotherapy, none), all of the
polymeric membranes systematically degrade in vivo as a
function of implantation times (31−153 days). The differences
between the proximal and distal ends were identified and
explained in terms of various chemical natures of the body
fluids. This study was supported by the parallel in vitro tests in
simulated body fluids representative for gastric and saliva
environment. These findings have important practical
implications, pointing out the need for different optimization
of the material properties, specifically for each end of the stent.
The improvement of the chemical stability of the polymeric
material is of importance, since even a short implantation time
(35 days) led to significant changes in the surface and bulk
structure, as observed by DSC, DMTA, ATR-IR, SEM, CM,
and CA methods. The obtained results also show that the
contact angle and the polymer melting temperature can be
considered as suitable parameters for analyzing the extent of
the stent degradation processes. To the best of our knowledge,
this work is the only report in the literature that shows the
influence of chemo- and radiotherapy and the role of the
microenvironment of the esophagus and stomach in the
structure of the polyurethane/nitinol stents.
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